Phase 3 Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin

Trial Profile

Phase 3 Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SAIL
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Jan 2016 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 31 Jul 2014 According to the ClinicalTrials.gov record, planned end date changed to 1 Jun 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top